Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Farmers Insurance
Harvard Business School
Fish and Richardson
McKinsey
Baxter
UBS
Julphar

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006095

« Back to Dashboard

NDA 006095 describes TUBOCURARINE CHLORIDE, which is a drug marketed by Bristol Myers Squibb, Hospira, and Lilly, and is included in three NDAs. Additional details are available on the TUBOCURARINE CHLORIDE profile page.

The generic ingredient in TUBOCURARINE CHLORIDE is tubocurarine chloride. There are four drug master file entries for this compound. Additional details are available on the tubocurarine chloride profile page.
Summary for 006095
Tradename:TUBOCURARINE CHLORIDE
Applicant:Hospira
Ingredient:tubocurarine chloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 006095

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength3MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Cipla
UBS
QuintilesIMS
Moodys
Boehringer Ingelheim
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.